Mount Sinai Researchers Develop A Multi-Target Approach To Treating Tumors
June 7, 2012 – Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments. The result is an investigational compound …
Partnership Investment Fund Awards $1M to Support Four Promising Biomedical Products
June 4, 2012 – The Partnership for New York City (PFNYC) today announced that four local scientists have been awarded a total of $1 million to fund the final stages of research on new biomedical products that will be developed in the …
Ivan Galanin Appointed to Head Commercial Development at Mount Sinai School of Medicine’s Office of Technology and Business Development
April 10, 2012 – Ivan Galanin, an experienced research and development strategist, has joined Mount Sinai School of Medicine as Director of Commercial Development in the Office of Technology and Business Development. His appointment will begin April 9, 2012. Reporting to Teri …
CommonMind Consortium Launched as a Public-Private Effort to Generate and Broadly Share Molecular Data on Neuropsychiatric Disease
April 9, 2012 – Sage Bionetworks, Mount Sinai School of Medicine (MSSM), University of Pennsylvania (Penn), the National Institute of Mental Health (NIMH), and Takeda Pharmaceuticals Company Limited (TAKEDA) have launched a Public-Private Pre-Competitive Consortium to generate and analyze large-scale genomic data …
Mount Sinai School of Medicine and MRC Technology To Collaborate On Monoclonal Antibody Production and Humanization
April 3, 2012 – The Mount Sinai Medical Center and MRC Technology (MRCT), the technology transfer organization for the United Kingdom’s prestigious Medical Research Council, have reached an agreement to collaborate on the development of monoclonal antibodies that can be commercialized as …